Feature | February 01, 2022 | By Dave Fornell, DAIC Editor

Most Popular Cardiology Content in January 2022

By far the two biggest news items from January included the first pig heart transplant into a human patient at the University of Maryland Medical Center, and the FDA clearance of Novarti's inclisiran (Leqvio) twice annual dose injectable LDL lowering drug.

By far the two biggest news items from January included the first pig heart transplant into a human patient at the University of Maryland Medical Center, and the FDA clearance of Novarti's inclisiran (Leqvio) twice annual dose injectable LDL lowering drug.



Additional Content

News | Cardiovascular Surgery

May 4, 2026 — Johnson & Johnson recently announced new data from a novel U.S. pilot single-arm trial that evaluated the ...

Home May 05, 2026
Home
News | Cardiovascular Surgery

March 24, 2026 — iPerf, a company specializing in the development of medical devices for cardiopulmonary support, has ...

Home March 25, 2026
Home
News | Cardiovascular Surgery

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Home February 13, 2026
Home
News | Cardiovascular Surgery

Feb. 11, 2026 – Columbia HeartSource, an extension of Columbia University Irving Medical Center’s Department of Surgery ...

Home February 12, 2026
Home
News | Cardiovascular Surgery

Feb. 6, 2026 — Robert Wood Johnson University Hospital (RWJUH), in partnership with Rutgers Robert Wood Johnson Medical ...

Home February 06, 2026
Home
Subscribe Now